INNOVENTIS PHARMA
The computed 12-month bankruptcy probability of INNOVENTIS PHARMA is 0.6% (low). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 8 yrs |
| Board | 1 |
| Locations | 1 |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | verkort | 15-12-2025 | 2025-00582966 |
| 31-12-2023 | verkort | 15-06-2024 | 2024-00134640 |
| 31-12-2022 | verkort | 29-08-2023 | 2023-00383160 |
| 31-12-2021 | verkort | 03-11-2022 | 2022-20516686 |
| 31-12-2020 | verkort | 09-12-2021 | 2021-79800151 |
| 31-12-2019 | verkort | 08-08-2020 | 2020-40300314 |
| 31-12-2018 | micro | 11-07-2019 | 2019-34200533 |
-
GERMAIN Frédéric JeanPaulSole directorState Gazette act 24368204 (27-02-2024)Current08-02-2024 → present
Former directors (2)
-
Former- → 08-02-2024
-
Former- → 08-02-2024
| NACE primary | Groothandel in parfumerieën en cosmetica(46450) |
| Legal form | Public limited company(014) |
| Incorporation | 21-02-2018 |
| Status | Active |
| Postal code | 9250 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42342C1246/00G000 | Flanders | 486 m² | 1 · 125 m² | 15.8 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
14-04-2025 Articles of association amended, name change, change of corporate purpose and translation of the articles
Technical details
{
"notary": {
"name": "Lisa SCHAMP",
"firm_city": null,
"firm_name": "Deckers notarissen",
"office_city": "Antwerpen",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-04-14",
"filing_date": "2025-04-10",
"act_kind_objet": "DOEL, MAATSCHAPPELIJKE ZETEL, BENAMING, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-03-31",
"unanimous": null
},
"statute_change": {
"kinds": [
"name_change",
"object_change",
"translation",
"coordination"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "nl",
"language_before": "nl"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0690.813.115",
"name_full_after": "INNOVENTIS PHARMA",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "INNOVENTIS ONE",
"current_zetel_raw": "Boomstraat(BOR) 85 2880 Bornem",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [],
"articles_modified": [
{
"summary": "De rechtsvorm van de vennootschap is bevestigd als naamloze vennootschap en de naam is gewijzigd in INNOVENTIS PHARMA.",
"new_text": "De vennootschap heeft de rechtsvorm van een naamloze vennootschap. Zij draagt de naam INNOVENTIS PHARMA.",
"change_kind": "amended",
"article_title": null,
"article_number": "1"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Lisa SCHAMP",
"org_rep_person_name": null
},
"co_filed_documents": [
"afschrift van de akte",
"volmachten",
"geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
],
"shareholder_rights": null,
"voorwerp_change_summary": "Het voorwerp van de vennootschap is uitgebreid en aangepast om de activiteiten in de voedingssector, de handel in cosmetica en modeaccessoires, het beheer van onroerend en roerend vermogen, en het beleggen in diverse activa zoals aandelen en obligaties om te vatten.",
"capital_structure_change": null,
"coordinated_text_lineage": null
}27-02-2024 Capital increase of €500,000 to €561,500
- €61.500 → €561.500
Technical details
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 561500.0,
"delta_eur": 500000.0,
"before_eur": 61500.0,
"share_emission": {
"agio_eur": 0.0,
"share_form": "no_nominal_value",
"share_class": "B",
"n_new_shares": 20325,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "schuldvordering_inbreng",
"paid_up_delta_eur": 500000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Tine Landuydt",
"firm_city": null,
"firm_name": null,
"office_city": "Mortsel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-27",
"filing_date": "2024-02-23",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-02-08",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-02-08"
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "Luc Callaert Bedrijfsrevisor BV",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Luc Callaert"
},
"subject_company": {
"kbo": "0690.813.115",
"name_full": "INNOVENTIS ONE",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tine Landuydt",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"afschrift van de akte van 08/02/2024",
"de geco\u00F6rdineerde tekst van statuten",
"De 2 voormelde verslagen van het bestuursorgaan",
"De 2 voormelde verslagen van de bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 2500,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 20325,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 0.0
}
]
}| Legal nameNL | INNOVENTIS PHARMA |